论文部分内容阅读
随机抽取2型糖尿病患者92例作为本次研究对象,按不同的治疗方法,将接受口服降糖药物治疗的46例患者作为对照组,将接受口服降糖药物联合甘精胰岛素治疗的46例患者作为观察组,对两组的临床效果进行统计分析。结果:观察组治疗后空腹血糖、餐后2h血糖水平均低于对照组,差异有统计学意义(P<0.05);观察组治疗有效率(95.65%)高于对照组(80.43%),差异有统计学意义(P<0.05)。结论:对2型糖尿病疾病的治疗,在口服降糖药物治疗基础上联合甘精胰岛素治疗的疗效较佳,改善患者预后,值得临床大力推荐。
Forty-two patients with type 2 diabetes were randomly selected as the study object. According to different treatment methods, 46 patients receiving oral hypoglycemic drugs as control group, 46 patients receiving oral hypoglycemic agents combined with insulin glargine As the observation group, the clinical effects of the two groups were statistically analyzed. Results: The fasting blood glucose and postprandial blood glucose 2 h after treatment in the observation group were lower than those in the control group (P <0.05). The effective rate in the observation group (95.65%) was higher than that in the control group (80.43%), There was statistical significance (P <0.05). Conclusion: The treatment of type 2 diabetes mellitus is better than oral glargine in the treatment of type 2 diabetes mellitus, and the improvement of prognosis is worthy of clinical recommendation.